SBIR Phase II: Enabling High Output Metabolism in Plant Cells
Small Business Information
KAS (Currently Kuehnle AgroSystems Corporation)
2800 Woodlawn Drive, Honolulu, HI, 96822
AbstractThis Small Business Innovation Research (SBIR) Phase II project aims to develop and validate a novel chloroplast transformation vector for protein expression in chloroplasts. The research project will broaden scientific understanding of the parameters of chloroplast transformation by addressing stoichiometric expression of multiple transgenes for effective engineering of pathways such as carotenogenesis, feedback regulation and expression of multimeric proteins. The commercial impact of this technology will provide an enabling strategy for expression of genes of interest in chloroplasts to potentially increase the production of high value nutraceutical and pharmaceutical compounds. Application of this technology for stable, high output metabolism with regulatory compliance will reduce production cost and increase the reliability for downstream processing and eventual commercialization.
* information listed above is at the time of submission.